Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Sep 29, 2020 8:03 AM ET

Healthcare CRO Services Market Predicted to Witness Sustainable Evolution in Years to Come | IQVIA, PRA Health Sciences, ICON, Syneos Health, Evotec


iCrowd Newswire - Sep 29, 2020

Healthcare CRO Services Market by Type (Early Phase Development, Clinical Development Services, Laboratory Services, and Consulting Services), Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Diabetes, and Others), and End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2019-2026, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare CRO Services market, and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Healthcare CRO Services market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence. Get complete Report (Including Full TOC, List of Tables & Figures, Chart). – In-depth Analysis Pre & Post COVID-19 Market Estimates

The global healthcare contract research organization (CRO) services market was valued at $38,996.9 million in 2018 and is expected to reach $66,036.6 million by 2026, registering a CAGR of 6.9% from 2019 to 2026.

Download Free Sample Copy of ‘Healthcare CRO Services market’ Report @ (Exclusive Offer)

https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR711

Key Segments Studied in the Global Healthcare CRO Services Market:

Professional Key players:  IQVIA,   PRA Health Sciences,   ICON,   Syneos Health,   Evotec,   Charles River, Medpace,   Labcorp,   Biotelemetry,   Syngene

By Service Type

– Early Phase Development,  – Clinical Research Services,  – Laboratory Services,  – Consulting Services

By Therapeutic Area

– Oncology,  – CNS Disorder,  – Cardiovascular Disease,  – Metabolic Disease, – Infectious Disease, – Diabetes, – Others

By End-User

– Pharmaceutical Companies,   – Medical Device Companies,  – Academic Institutes

Contract research organizations (CROs) are outsourcing companies or groups that conduct specific and focused R&D clinical trials for the pharmaceutical or biotech industry. They possess well-experienced professionals that offer preclinical, clinical, and regulatory activities for drug and medical devices development, and their commercialization. These organizations can range from international full-service groups to small or niche service providing groups. In addition, CROs provide the experience of moving a novel drug, molecule, or a drug from its nascent phase to marketing approval, without any involvement of a sponsor for these services.

Surge in R&D for the development of novel drugs and medical devices and rise in healthcare expenditure are the major factorsthat drive the market growth. Moreover, CROs help in saving time and extra cost of manufacturers as it reduces the time to conduct a trial compared to the time taken for doing the same trials in-house, whichleadsto significant cost savings. However, penetrating competition in the market and dearth of skilled professionals are the major factors anticipated to hamper the market growth. Moreover, rise in the biotech and pharmaceutical sector in developing economies is expected to create lucrative opportunities for the market.

The market is segmented on the basis of service type, therapeutic area, end-users, and region. By service type, it is categorized into early phase development, clinical development services, laboratory services, and consulting services. By therapeutic area, it is segmented into oncology, CNS disorder, cardiovascular disease, metabolic disease, infectious disease, diabetes, and others. By end-users it is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

A combination of factors, including COVID-19 containment situation, end-use market recovery & Recovery Timeline of 2020/ 2021

covid-19 scenario Market Behavior/ Level of Risk and Opportunity End Industry Behavior/ Opportunity Assessment Expected Industry Recovery Timeline Business Impact Horizon
Opening of Economy by Q3 2020 xx xx xx xx
Recovery – Opening of Economy extended till Q4 2020 / Q1 2021 xx xx xx xx

Geographical Breakdown: Regional level analysis of the market, currently covering North America, Europe, China & Japan

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

In-Depth Qualitative COVID 19 Outbreak Impact Analysis Include Identification And Investigation Of The Following Aspects: Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porter’s Fiver Forces. The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios. The report basically gives information about the market trends, growth factors, limitations, opportunities, challenges, future forecasts, and details about all the key market players.

(Check Our Exclusive Offer: Ask for Discount to our Representative)

https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR711

Changing Forecasts in a Time of Crisis: explores key issues, including:

 Ask Our Expert for Complete Report@:

https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR711

Key Points Covered in Healthcare CRO Services Market Report:

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter’s five forces analysis
3.1. Key Findings
3.1.1. Top Investment Pockets
3.2. Top player positioning
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Rise in R&D investment
3.3.1.2. Significant increase in cancer incidence across the globe
3.3.2. Restraints
3.3.2.1. Dearth of skilled labors/healthcare professionals
3.3.3. Opportunities
3.3.3.1. Various growth opportunities in emerging economies
CHAPTER 4: HEALTHCARE CRO SERVICES MARKET, BY SERVICE TYPE
4.1. Overview
4.1.1. Market size and forecast, by service type
4.2. Early phase development
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Clinical development services
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Laboratory Services
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Consulting Services
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: CRO SERVICES MARKET, BY THERAPEUTIC AREA
5.1. Overview
5.1.1. Market size and forecast, by therapeutic area
5.2. Oncology
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. CNS Disorder
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Cardiovascular disease
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Metabolic disease
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Infectious disease
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Diabetes
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
5.8. Others
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by country
CHAPTER 6: CRO SERVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast, by end user
6.2. Pharmaceutical & biopharmaceutical companies
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Medical device companies
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Academic institutes
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: CRO SERVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by service type
7.2.4. Market size and forecast, by therapeutic area
7.2.5. Market size and forecast, by end user
7.2.5.1. U.S. market size and forecast, by service type
7.2.5.2. U.S. market size and forecast, by therapeutic area
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by service type
7.2.5.5. Canada market size and forecast, by therapeutic area
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by service type
7.2.5.8. Mexico market size and forecast, by therapeutic area
7.2.5.9. Mexico CRO services MARKET, by end user
7.3. Europe
7.3.1. Key market trends
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by service type
7.3.4. Market size and forecast, by therapeutic area
7.3.5. Market size and forecast, by end user
7.3.5.1. France market size and forecast, by service type
7.3.5.2. France market size and forecast, by therapeutic area
7.3.5.3. France market size and forecast, by end user
7.3.5.4. UK market size and forecast, by service type
7.3.5.5. UK market size and forecast, by therapeutic area
7.3.5.6. UK market size and forecast, by end user
7.3.5.7. Germany market size and forecast, by service type
7.3.5.8. Germany market size and forecast, by therapeutic area
7.3.5.9. Germany market size and forecast, by end user
7.3.5.10. Spain market size and forecast, by service type
7.3.5.11. Spain market size and forecast, by therapeutic area
7.3.5.12. Spain market size and forecast, by end user
7.3.5.13. Rest of Europe market size and forecast, by service type
7.3.5.14. Rest of Europe market size and forecast, by therapeutic area
7.3.5.15. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by therapeutic area
7.4.4. Market size and forecast, by end user
7.4.4.1. Japan market size and forecast, by service type
7.4.4.2. Japan market size and forecast, by therapeutic area
7.4.4.3. Japan market size and forecast, by end user
7.4.4.4. China market size and forecast, by service type
7.4.4.5. China market size and forecast, by therapeutic area
7.4.4.6. China market size and forecast, by end user
7.4.4.7. India market size and forecast, by service type
7.4.4.8. India market size and forecast, by therapeutic area
7.4.4.9. India market size and forecast, by end user
7.4.4.10. Australia market size and forecast, by service type
7.4.4.11. Australia market size and forecast, by therapeutic area
7.4.4.12. Australia market size and forecast, by end user
7.4.4.13. Rest of Asia-Pacific market size and forecast, by service type
7.4.4.14. Rest of Asia-Pacific market size and forecast, by therapeutic area
7.4.4.15. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by service type
7.5.4. Market size and forecast, by therapeutic area
7.5.5. Market size and forecast, by end user
7.5.5.1. Brazil market size and forecast, by service type
7.5.5.2. Brazil market size and forecast, by therapeutic area
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. South Africa market size and forecast, by service type
7.5.5.5. South Africa market size and forecast, by therapeutic area
7.5.5.6. South Africa market size and forecast, by end user
7.5.5.7. Saudi Arabia market size and forecast, by service type
7.5.5.8. Saudi Arabia market size and forecast, by therapeutic area
7.5.5.9. Saudi Arabia market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by service type
7.5.5.11. Rest of LAMEA market size and forecast, by therapeutic area
7.5.5.12. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. BioTelemetry Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. CHARLES RIVER LABORATORIES Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. ICON.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. IQVIA
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Evotec SE
8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Product portfolio
8.5.4. Business performance
8.6. Laboratory Corporation of America Holdings
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio
8.6.4. Business performance
8.7. Medpace, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. PRA Health Science
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Syngene International Limited
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Syneos Health
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance

Continued….

……..and view more in complete table of Contents

Browse Premium Research Report with Tables and Figures at @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR711

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.



Contact Information:

Get in Touch with Us:
Report Ocean
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/
Blog: https://reportoceanblog.com/






Keywords:    Healthcare CRO Services Market, Healthcare CRO Services Market Analysis, Healthcare CRO Services Market Growth, Healthcare CRO Services Market Scope, Healthcare CRO Services Market Share, Healthcare CRO Services Market Trend, Healthcare CRO Services Market Development, Healthcare CRO Services Market Sales, Healthcare CRO Services Market Forecast, Healthcare CRO Services Market Opportunities, Healthcare CRO Services Market Size

Tags:    IPS, Reportedtimes, iCN Internal Distribution, Research Newswire, English